Gian Life Care Ltd Stock Price Today (NSE: GIANLIFE)
Fundamental Score
Gian Life Care Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Gian Life Care Ltd share price today is ₹6.06, up +1.00% on NSE/BSE as of 22 June 2026. Gian Life Care Ltd (GIANLIFE) is a Small-cap company in the Healthcare Service Provider sector with a market capitalisation of ₹10.98 (Cr). The 52-week high for GIANLIFE share price is ₹17.49 and the 52-week low is ₹5.43. The company has a Return on Equity (ROE) of -0.21% and a debt-to-equity ratio of 0.30.
Gian Life Care Ltd Share Price Chart — NSE/BSE Historical Performance
Gian Life Care Ltd share price chart: -12.57% return over the past month. 52-week high ₹17.49, 52-week low ₹5.43.
Gian Life Care Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹6.19 | ₹6.19 | ₹5.73 | ₹6.06 | 600.00 (Cr) | |
| ₹5.57 | ₹6.01 | ₹5.57 | ₹6.00 | 35.07K (Cr) | |
| ₹5.98 | ₹6.06 | ₹5.70 | ₹5.74 | 4.57K (Cr) | |
| ₹6.08 | ₹6.08 | ₹5.78 | ₹5.98 | 3.94K (Cr) | |
| ₹6.14 | ₹6.14 | ₹5.60 | ₹6.08 | 17.59K (Cr) | |
| ₹6.29 | ₹6.29 | ₹5.88 | ₹5.89 | 12.08K (Cr) | |
| ₹6.28 | ₹6.35 | ₹5.90 | ₹6.18 | 14.90K (Cr) | |
| ₹6.26 | ₹6.26 | ₹5.95 | ₹6.21 | 3.97K (Cr) | |
| ₹6.48 | ₹6.48 | ₹5.96 | ₹5.98 | 8.71K (Cr) | |
| ₹6.20 | ₹6.38 | ₹6.02 | ₹6.27 | 16.32K (Cr) |
Gian Life Care Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹5.57 | ₹6.19 | ₹5.57 | ₹6.06 | +8.80% | |
| ₹6.35 | ₹6.60 | ₹5.43 | ₹5.74 | -9.61% | |
| ₹6.14 | ₹7.23 | ₹5.84 | ₹6.30 | +2.61% | |
| ₹8.13 | ₹8.95 | ₹5.90 | ₹6.14 | -24.48% | |
| ₹10.58 | ₹10.88 | ₹8.18 | ₹8.55 | -19.19% | |
| ₹8.73 | ₹10.73 | ₹7.98 | ₹9.97 | +14.20% | |
| ₹11.16 | ₹11.16 | ₹7.08 | ₹8.38 | -24.91% | |
| ₹12.41 | ₹13.23 | ₹11.16 | ₹11.17 | -9.99% | |
| ₹15.80 | ₹15.80 | ₹12.00 | ₹12.41 | -21.46% | |
| ₹15.33 | ₹16.79 | ₹13.60 | ₹15.55 | +1.44% | |
| ₹15.20 | ₹17.49 | ₹13.56 | ₹14.85 | -2.30% | |
| ₹14.72 | ₹16.88 | ₹13.52 | ₹14.94 | +1.49% |
AI Research Briefing
Powered by Gemini · 2026-04-15
This micro-cap is a governance dumpster fire; auditors can't even verify the cash.
WHAT'S HAPPENING NOW (last 2-4 weeks)
Gian Life Care entered a 5-year lab management services agreement with Brahma Hospital (HUF) in Roorkee, starting March 2026. This contract is projected to add Crore to annual revenue and -20 Lakhs to annual net profit. Q3 FY26 results (ended Dec 31, 2025) showed a YoY decline: Revenue down 29.3% to Cr, EBITDA down 47.3% to Cr, and PAT down 70.7% to Cr. Auditors issued a modified report flagging a Cr cash balance despite unpaid statutory dues of Cr and a defaulted bank loan of Cr classified as an NPA.
CORE STORY (THE REAL GAME)
This is a micro-cap healthcare service provider struggling with profitability and governance issues, attempting to ride the broader India healthcare growth narrative. The market is likely pricing in turnaround hopes based on new contracts, but significant red flags remain.
- New lab management contract with Brahma Hospital
- India healthcare sector projected to reach ₹54,67,022 crore by 2025
- Stock trading near 52-week low
- Significant earnings beat with clean audit
- Major new contract wins
- Promoter unpledging shares
- Auditors unable to verify ₹7.44 Cr cash balance
- Unpaid statutory dues of ₹4.27 Cr and NPA of ₹3.60 Cr
- High promoter pledging (61.17%)
No FII or DII holding. Promoter holding steady at 32.09%, but heavily pledged.
India's healthcare sector is growing, but this company is unlikely to benefit due to internal issues.
Gian Life Care entered a five-year agreement with Brahma Hospital (HUF) for lab management services in Roorkee, starting March 2026. The contract is projected to contribute approximately ₹1 Crore to annual revenue and ₹18-20 Lakhs to annual net profit.
No free cash flow generation.
Even with the new contract, the company's financial health and governance issues raise serious concerns. Unlikely to see sustained improvement in the next 3-6 months.
Primary Thesis Risk
Auditor's inability to verify cash balance suggests potential fraud.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Gian Life Care Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Gian Life Care Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of GIANLIFE across key market metrics for learning purposes.
Positive Indicators
1 factors identified
Conservative Debt Levels (D/E: 0.30)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Risk Factors
7 factors identified
Below-Average Return on Equity (-0.21%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (2.40%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Profit Decline Concern (-44.44%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Revenue Contraction (-56.06%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Weak Interest Coverage (0.93x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability.
High Share Pledging Risk (61.17%)
Observation: Significant promoter share pledging creates potential overhang.
Analysis: High pledging levels may create selling pressure during market downturns.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Gian Life Care Ltd vs Healthcare Service Provider Peers
Peer Comparison - Healthcare Service Provider
Compare Gian Life Care Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Gian Life Care LtdGian Life Care ...Selected✓ GIANLIFE • 542918 | 0/100 | ₹6.06₹6 | ₹10.98₹10.98 | — — | -0.21%Poor -0.21% Poor | 2.40%Poor 2.40% Poor | 0.30Excellent 0.3 Excellent | — — | — — | 0.00% |
Dr Lal PathLabs LtdDr Lal PathLabs... LALPATHLAB • 539524 | 64.3/100 | ₹1577.00₹1577 | ₹25557.40₹25557.40 | 47.83Average 47.8 Average | 24.30%Excellent 24.30% Excellent | 28.88%Excellent 28.88% Excellent | 0.07Excellent 0.1 Excellent | 16.69%Excellent 16.69% Excellent | 13.09%Good 13.09% Good | 0.79% |
Vijaya Diagnostic Centre LtdVijaya Diagnost... VIJAYA • 543350 | 53.7/100 | ₹1237.00₹1237 | ₹10272.45₹10272.45 | 67.39Average 67.4 Average | 19.00%Good 19.00% Good | 20.91%Excellent 20.91% Excellent | 0.42Excellent 0.4 Excellent | 18.97%Excellent 18.97% Excellent | 15.00%Excellent 15.00% Excellent | 0.20% |
Metropolis Healthcare LtdMetropolis Heal... METROPOLIS • 542650 | 48.9/100 | ₹541.30₹541 | ₹10124.28₹10124.28 | 63.98Average 64.0 Average | 11.53%Average 11.53% Average | 14.66%Average 14.66% Average | 0.14Excellent 0.1 Excellent | -0.56%Poor -0.56% Poor | 9.22%Good 9.22% Good | 0.20% |
Thyrocare Technologies LtdThyrocare Techn... THYROCARE • 539871 | 40.5/100 | ₹522.75₹523 | ₹7724.80₹7724.80 | 60.48Average 60.5 Average | 16.15%Good 16.15% Good | 24.78%Excellent 24.78% Excellent | 0.05Excellent 0.1 Excellent | -0.64%Poor -0.64% Poor | 9.62%Good 9.62% Good | 1.44% |
Krsnaa Diagnostics LtdKrsnaa Diagnost... KRSNAA • 543328 | 39.6/100 | ₹542.65₹543 | ₹2626.09₹2626.09 | 30.73Average 30.7 Average | 9.29%Poor 9.29% Poor | 12.52%Average 12.52% Average | 0.30Excellent 0.3 Excellent | 22.05%Excellent 22.05% Excellent | 21.41%Excellent 21.41% Excellent | 0.34% |
Suraksha Diagnostic LtdSuraksha Diagno... SURAKSHA • 544293 | 47.1/100 | ₹281.15₹281 | ₹1534.08₹1534.08 | 48.05Average 48.0 Average | 16.46%Good 16.46% Good | 17.84%Good 17.84% Good | 0.51Good 0.5 Good | 16.38%Excellent 16.38% Excellent | 9.86%Good 9.86% Good | 0.00% |
3B Blackbio Diagnostics Ltd3B Blackbio Dia... 3BBLACKBIO • 532067 | 66.1/100 | ₹1099.00₹1099 | ₹1080.56₹1080.56 | 22.01Average 22.0 Average | 19.40%Good 19.40% Good | 25.75%Excellent 25.75% Excellent | 0.00Excellent 0.0 Excellent | 44.03%Excellent 44.03% Excellent | 27.29%Excellent 27.29% Excellent | 0.32% |
One Global Service Provider IncOne Global Serv... ONEGLOBAL • 514330 | 69.5/100 | ₹467.55₹468 | ₹1070.08₹1070.08 | 24.39Average 24.4 Average | 42.31%Excellent 42.31% Excellent | 56.38%Excellent 56.38% Excellent | 0.00Excellent 0.0 Excellent | 128.82%Excellent 128.82% Excellent | — — | 0.00% |
Sastasundar Ventures LtdSastasundar Ven... SASTASUNDR • 533259 | 40.3/100 | ₹307.25₹307 | ₹1042.27₹1042.27 | — — | 4.63%Poor 4.63% Poor | -1.33%Poor -1.33% Poor | 0.01Excellent 0.0 Excellent | 23.31%Excellent 23.31% Excellent | 24.47%Excellent 24.47% Excellent | 0.00% |
46.5/100 | ₹227.50₹228 | ₹826.72₹826.72 | 30.47Average 30.5 Average | 27.08%Excellent 27.08% Excellent | 28.85%Excellent 28.85% Excellent | 0.48Excellent 0.5 Excellent | — — | — — | 0.00% | |
Top Healthcare Service Provider Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Dr Lal PathLabs Ltd share price25557.40 Cr
- Vijaya Diagnostic Centre Ltd share price10272.45 Cr
- Metropolis Healthcare Ltd share price10124.28 Cr
- Thyrocare Technologies Ltd share price7724.80 Cr
- Krsnaa Diagnostics Ltd share price2626.09 Cr
Gian Life Care Ltd Quarterly Performance
Latest quarterly metrics for GIANLIFE — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
-56.06%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-44.44%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
N/A
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
N/A
Compounded annual net profit growth over 5 years
Gian Life Care Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for GIANLIFE — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Gian Life Care Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Gian Life Care Ltd (GIANLIFE) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Gian Life Care Ltd
About GIANLIFE (Gian Life Care Ltd)
Gian Life Care Ltd is a burgeoning healthcare service provider dedicated to revolutionizing diagnostics and wellness solutions. With a foundation built on precision and patient-cen...tricity, GIANLIFE strives to empower individuals to take proactive control of their health. The company operates under the core belief that accurate and timely diagnostics are paramount for effective healthcare management. Through a comprehensive suite of services, GIANLIFE serves as a trusted partner for patients, medical professionals, and organizations seeking reliable insights into health status. Their commitment extends beyond mere testing, embracing a holistic approach to preventative care and personalized wellness strategies. Located in India, GIANLIFE endeavours to cater to the evolving healthcare needs of the local community. At the heart of GIANLIFE lies a diverse portfolio of diagnostic tests, spanning crucial areas of medical science. From advanced biochemistry and clinical pathology to intricate cytogenetic and cytology analyses, GIANLIFE offers a broad spectrum of testing options. These services are designed to uncover a wealth of information, aiding in the early detection, diagnosis, and monitoring of various health conditions. Employing cutting-edge technology and rigorous quality control measures, GIANLIFE ensures the accuracy and reliability of its results. The company's expert team of professionals diligently interprets the data, providing comprehensive reports that inform clinical decision-making. GIANLIFE is committed to serving a diverse clientele, including individual patients seeking clarity about their health, healthcare providers looking for dependable diagnostic support, and corporate entities invested in employee well-being. By delivering efficient and accessible services, GIANLIFE aims to contribute to the overall health and prosperity of the community. From routine check-ups to specialized investigations, the company caters to a wide array of healthcare needs. With a focus on fostering trust and delivering exceptional service, GIANLIFE strives to be a beacon of excellence in the Indian healthcare landscape.
Company Details
Key Leadership
GIANLIFE Share Price: Frequently Asked Questions
What is the current share price of Gian Life Care Ltd?
Gian Life Care Ltd (GIANLIFE) trades at ₹6.06 on NSE and BSE. Market cap ₹10.98 (Cr). Educational data only.
What is the P/E ratio of Gian Life Care Ltd?
Gian Life Care Ltd has a P/E of N/Ax vs industry average 39.28x.
What is the Bull Run score for Gian Life Care Ltd?
Gian Life Care Ltd has a Bull Run score of 0/100 based on 25+ financial parameters.
Does Gian Life Care Ltd pay dividends?
Gian Life Care Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Gian Life Care Ltd?
Gian Life Care Ltd has ROE of -0.21%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Gian Life Care Ltd?
Gian Life Care Ltd has debt-to-equity of 0.30.
Is Gian Life Care Ltd a good investment?
Bull Run gives Gian Life Care Ltd a score of 0/100. This is not investment advice — consult a SEBI-registered advisor.